LimJiaWen_TMA01 - BUS488 Strategy Assignment 2 Individual Assignment 1\/TMA01 January 2017 Presentation Student Name Lim Jia Wen Student No E1370157 0

LimJiaWen_TMA01 - BUS488 Strategy Assignment 2 Individual...

This preview shows page 1 - 6 out of 21 pages.

BUS488 Strategy Assignment 2 - Individual Assignment 1/TMA01 January 2017 Presentation Student Name Student No. Lim Jia Wen E1370157 0
Image of page 1
Content Page Descriptions Page No. Qn 1a 1 - 5 Qn 1b 5- 10 Qn 2 a 11 Qn 2 b 12 Qn 2 c 13 Qn 3a 14 Qn 3b 15 Qn 4 a -b 16 - 18 Qn 5 19 References 20 0
Image of page 2
Question 1 1a. Industry and timeline The industry in which Pfizer Inc operated is pharmaceutical industry in the global region. The type of business is B2C. The analysis period is from 1996 – 2006. 1a. PESTEL analysis Factors Explanation (with supporting case evidence) Opportunit y Threat Political FDA imposed severe restrictions on what could claim as the drug’s benefit. (pg 3-4, para 6). It is a threat because the players have to work hard to get the approval in order to sell its drug. It is an opportunity because only approved drug will get to see its potential market and relevant patient population. U.S granted patent protection of 17-20 years to new chemical entities (pg 5, para 1). It is an opportunity as the patent drug can only be manufactured and market by the company that developed. It is a threat because once the patent expired; other players may manufacture and sold the drug. Differential pricing strategy due to government intervention. (pg 7 para 1). It is a threat because cheaper drugs may be bought at one country like Canada and resold for a premium in another. Question 1 1
Image of page 3
Question 1 1a. PESTEL analysis 2
Image of page 4
Image of page 5
Image of page 6

You've reached the end of your free preview.

Want to read all 21 pages?

  • Spring '17
  • pg, Drug development, Pfizer Inc

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture

  • Left Quote Icon

    Student Picture